Nathan L Board

8PUBLICATIONS
61CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Naturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice.

|Feb 24, 2026
Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones.

Isabella A T M Ferreira, Alberto Herrera, Tan Thinh Huynh

|Nov 24, 2025
A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice.

Zhe Yuan, Nathan L Board, Miaoyun Zhao

|Aug 13, 2025
Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.

Fengting Wu, Milica Moskovljevic, Filippo Dragoni

|Jan 26, 2024
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells.

Nathan L Board, Zhe Yuan, Fengting Wu

|Apr 14, 2023
A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.

Srona Sengupta, Josephine Zhang, Madison C Reed

Pageof 2

Frequent Collaborators

4 joint publications

Luis J Montaner

4 joint publications

Robert F Siliciano

3 joint publications

Milica Moskovljevic

3 joint publications

Janet D Siliciano